Biotech stock TG Therapeutics is outperforming the major indexes in a declining stock market. TGTX stock hit a new high on ...

However, TG Therapeutics’ strong earnings overshadowed market downturns, supporting its share price, while the broader market was influenced by mixed news from tech and manufacturing sectors ...

Multiple Sclerosis News Today reported that TG Therapeutics has set the list price for Briumvi at $59,000 per year, which is the lowest list price for any branded MS therapy currently on the market.

MORRISVILLE, N.Y. (AP) — MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported fourth-quarter earnings of $23.3 million. On a per-share basis, the Morrisville, New York-based company ...